<DOC>
	<DOCNO>NCT02860156</DOCNO>
	<brief_summary>This multicenter clinical trial cross section HIV+ patient without diastolic dysfunction . Approximately 200 HAART-treated virally suppress HIV+ subject ( 100 HIV+/DD+ &amp; 100 HIV+/DD- ) enrol . This study evaluate biomarkers , phenomapping , metabolomics , cMRI , echocardiography determine characteristic unique patient population .</brief_summary>
	<brief_title>Characterizing HIV-related Diastolic Dysfunction</brief_title>
	<detailed_description>With advent highly active antiretroviral therapy ( HAART ) , human immunoÂ¬deficiency virus ( HIV ) type 1 infection become chronic disease . The proportion patient expect survive 5 , 10 , 15 year conversion HAART era 99 % , 93 % 89 % respectively . With increased life expectancy decrease morbidity opportunistic infection , importance chronic complication associate HIV-1 infection , include HF become evident . The advent HAART alter epidemiology HIV associate cardiomyopathy evolve primarily leave ventricular systolic dysfunction grow recognition leave ventricular DD . DD associate development atrial fibrillation heart failure ( HF ) , portend high risk all-cause mortality . Thus widespread prevalence cardiac abnormality HIV infect individual associate HF development may represent sub-clinical abnormality may potentially intervene upon reduce risk subsequent HF . There little data understand natural history pathogenesis cardiac abnormality , specifically DD HIV+ individual , may adversely affect longevity quality life individual .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1 . Age &gt; 40 year 2 . Willingness ability provide inform consent 3 . HIV antibody positive 4 . On HAART &gt; 6 month ( HIV positive cohort ) 5 . History adequate viral suppression define HIV RNA level &lt; 200 copies/mL past 6 month 6 . LVEF &gt; 50 % 1 . Past EF &lt; 50 % 2 . Moderate severe valve stenosis regurgitation , past repair replacement 3 . Percutaneous surgical revascularization active angina 4 . Persistent atrial fibrillation 5 . BP &gt; 160mmHg SBP &gt; 100mmHg DBP 6 . Comorbid inflammatory disease ( e.g . RA SLE ) 7 . Active cancer cancer chemotherapy treatment prior year ( except skin cancer require chemotherapy radiation ) 8 . Chronic use steroid antiinflammatory therapy 9 . GFR &lt; 30 mL/min 10 . Active clinical trial investigational product 11 . Pregnant lactating female 12 . Contraindication cMR gadolinium injection ( severe claustrophobia , metal implant , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>